Results 221 to 230 of about 109,064 (360)

ATRX loss in adult gliomas lacking H3 alterations or IDH mutations, an exceptional situation for exceptional diagnoses: the experience of Sainte-Anne hospital. [PDF]

Acta Neuropathol Commun
Tauziède-Espariat A, Roux A, Benzakoun J, Kauv P, Tazi S, Métais A, Suwala AK, Hinz F, Hasty L, Filser M, Masliah-Planchon J, Saffroy R, Bucau M, Pallud J, Varlet P.   +14 more
europepmc   +1 more source

Astrocytoma [PDF]

, 2014
openaire   +1 more source

Canonical amplifications and CDKN2A/B loss refine IDH1/2-mutant astrocytoma prognosis. [PDF]

Neuro Oncol
Ghosh HS, Patel RV, Claus EB, Gonzalez Castro LN, Wen PY, Ligon KL, Meredith DM, Bi WL.   +7 more
europepmc   +1 more source

Subependymal Giant-cell Astrocytoma arising from the Trigone of the Lateral Ventricle

, 1987
Takashi Andoh, Morio Kumagai, Hiroaki Kondoh, Noboru Sakai, Hiromu Yamada, Kuniyasu Shimokawa   +5 more
openalex   +2 more sources

Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas [PDF]

, 1999
Hirofumi Hirano, M. Beatriz S. Lopes, Edward R. Laws, Tetsuhiko Asakura, Masamichi Goto, Joan E. Carpenter, Larry R. Karns, Scott R. VandenBerg   +7 more
openalex   +1 more source

Opportunities to Modulate Tumor Ecosystem Toward Successful Glioblastoma Immunotherapy

Cancer Science, Volume 116, Issue 6, Page 1482-1499, June 2025.
There remain outstanding gaps between the negative results from clinical trials and the actual potential of the immune system for glioblastoma. To bridge this crucial gap, we collaborated with Dr. Mariko Takahashi, an expert in immunobiology and drug development, and Dr. James J.
Mariko Takahashi, Darina Mukhamejanova, Himani Jasewicz, Nandini Acharya, James J. Moon, Toshiro Hara   +5 more
wiley   +1 more source

Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas [PDF]

, 1996
Hiroaki Wakimoto, Masaru Aoyagi, Takeo Nakayama, Goro Nagashima, Shinji Yamamoto, Masashi Tamaki, Kimiyoshi Hirakawa   +6 more
openalex   +1 more source

Case Series of Patients With FGFR1‐Related Pheochromocytoma and Paraganglioma With a Focus on Biochemical, Imaging Signatures and Treatment Options

Clinical Endocrinology, Volume 102, Issue 6, Page 626-634, June 2025.
ABSTRACT Pheochromocytoma and paraganglioma (together PPGL) are tumours with a high degree of heritability. Genetic landscape is divided into three clusters, cluster 1 (Krebs/pseudohypoxia signalling pathway), cluster 2 (kinase signalling pathway) and cluster 3 (Wnt signalling pathway).
Sakshi Jhawar, Abhishek Jha, Sara Talvacchio, Junne Kamihara, Jaydira Del Rivero, Karel Pacak   +5 more
wiley   +1 more source

Nephrogenic Diabetes Insipidus Associated with Temozolomide Therapy in a Patient with Grade IV Astrocytoma. [PDF]

Eur J Case Rep Intern Med
Fargouche Z, Manderlier M, Meert AP, Wolff L, Ilzkovitz M.   +4 more
europepmc   +1 more source

Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma [PDF]

, 1996
Anna I. Bakardjiev, Patrick D. Barnes, Liliana Goumnerova, Peter McL. Black, R. Michael Scott, Scott L. Pomeroy, Amy L. Billett, Jay S. Loeffler, N J Tarbell   +8 more
openalex   +1 more source